Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 2

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 2
---
 “us, “we”, “our”,
“HCTI” or the “Company”) by the selling stockholders identified in this prospectus. The number of shares the selling
stockholders may sell consists of (i) up to 7,017,429 shares of Common Stock purchased from us by the selling stockholders as part of
units (each a Unit”) pursuant to Securities Purchase Agreements (each a “Securities Purchase Agreement”) dated February
27, 2025 between us and the applicable selling shareholder; (ii) up to 29,173,056 shares of Common Stock that may be issued to the selling
stockholders if they fully exercise the pre-funded warrants (the “Pre-funded Warrants”) that were included in the Units; (iii)
361,904,850 shares of Common Stock that may be issued to the selling stockholders if they fully exercise the Series A warrants (the “Series
A Warrants”) that were included in the Units at the floor price of $0.084 per share and (iv) 1,085,714,550 shares of Common Stock
that may be issued to the selling stockholders if they fully exercise the Series B warrants (the “Series B Warrants” and together
with the Series A Warrants, the “Purchase Warrants”) using the “alternative cashless exercise” provided for in
the Series B Warrants and prior to such exercise, the exercise price for all of the shares underlying the Series B Warrants is reset to
the floor price of $0.084 per share.

The shares of Common Stock
covered by this prospectus have been or will be issued in reliance on exemptions from registration provided by Section 4(a)(2) of the
Securities Act, and Rule 506(b) promulgated thereunder. We are registering the shares of Common Stock to satisfy our obligations in connection
with registration rights we have granted to the selling stockholders pursuant to the terms of a Registration Rights Agreement, dated as
of February 28, 2025, by and between the Company and the selling stockholders (the “Registration Rights Agreement”).

We are not selling any shares
of our Common Stock in this offering and we will not receive any of the proceeds from the sale of shares of our Common Stock by the selling
stockholder. The selling stockholders will receive all of the proceeds from any sales of the shares of our Common Stock offered hereby,
but we will receive the proceeds from any cash exercises of the